摘要
生物节律是近年来研究的热点。生物节律紊乱是阿尔茨海默病(AD)患者的常见症状,通常被认为是AD的晚期后果。最近的研究表明,生物节律紊乱甚至在AD临床症状出现之前就已经发生。AD与生物节律紊乱之间的因果关系尚不清楚。阐明两者之间的关系有助于了解AD的发病机制,有助于AD的早期诊断。本文就生物节律相关参数在AD患者临床表现中的异常变化以及生物节律紊乱在AD中的作用进行综述。我们将讨论生物节律和AD之间的联系,重点是生物节律和AD过程之间的双向性。综上所述,这些最新研究成果可为进一步探讨心律在AD诊断和治疗中的意义提供依据。
关键词: 生物节律紊乱,老年痴呆症,双向互动,生物节律,生物钟基因,睡眠紊乱。
Current Alzheimer Research
Title:Altered Biological Rhythm and Alzheimer's Disease: A Bidirectional Relationship
Volume: 18 Issue: 9
关键词: 生物节律紊乱,老年痴呆症,双向互动,生物节律,生物钟基因,睡眠紊乱。
摘要: Biological rhythms have become the research focus in recent years. Biological rhythm disruption is a common symptom of Alzheimer's disease (AD) patients, which is usually considered as the late consequence of AD. Recent studies have shown that biological rhythm disruption even occurs before the onset of clinical symptoms of AD. The causal relationship between AD and biological rhythm disruption is not clear. Delineating their relationship can help understand the disease mechanisms and make the early diagnosis of AD possible. This review integrates the research on the abnormal changes of the biological rhythm-related parameters in the clinical manifestations of AD patients and the roles of the biological rhythm disorders in AD. We will discuss the links between biological rhythms and AD, with the focus on the bidirectionality between biological rhythms and AD processes. Collectively, these updated research findings may provide the basis for further exploring the significance of rhythm in the diagnosis and treatment of AD.
Export Options
About this article
Cite this article as:
Altered Biological Rhythm and Alzheimer's Disease: A Bidirectional Relationship, Current Alzheimer Research 2021; 18 (9) . https://dx.doi.org/10.2174/1567205018666211124104710
DOI https://dx.doi.org/10.2174/1567205018666211124104710 |
Print ISSN 1567-2050 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5828 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Biomimicry: Recent Updates on Nanotechnology Innovations Inspired by Nature Creations
Current Nanoscience Application of Nanobioinformatics in Medical Science – A Probable Therapy
Current Bioinformatics Chaperonopathies and Chaperonotherapy. Hsp60 as Therapeutic Target in Cancer: Potential Benefits and Risks
Current Pharmaceutical Design Prevalence of Tooth Wear in Primary Dentition in School Children of Abu Dhabi, UAE
Applied Clinical Research, Clinical Trials and Regulatory Affairs Nocturnal Hypertension, Nondipping Phenomenon and Target Organ Damage in Obstructive Sleep Apnea Patients - The Bad and the Worse
Current Respiratory Medicine Reviews Treatment-resistant Late-life Depression: Challenges and Perspectives
Current Neuropharmacology Progressive Supranuclear Palsy: What Do We Know About it?
Current Medicinal Chemistry Molecular Imaging with Small Animal PET/CT
Current Medical Imaging Breast Cancer: Current Developments in Molecular Approaches to Diagnosis and Treatment
Recent Patents on Anti-Cancer Drug Discovery Cytosolic Oligopeptidases: Features and Possible Physiopathological Roles in the Immune and Nervous Systems
Current Medicinal Chemistry - Central Nervous System Agents Didehydro-Cortistatin A Inhibits HIV-1 Tat Mediated Neuroinflammation and Prevents Potentiation of Cocaine Reward in Tat Transgenic Mice
Current HIV Research Renal COX-2, Cytokines and 20-HETE: Tubular and Vascular Mechanisms
Current Pharmaceutical Design Inhibition of Early Biochemical Defects in Prodromal Huntington’s disease by Simultaneous Activation of Nrf2 and Elevation of Multiple Micronutrients
Current Aging Science Regular Physical Activity and Vascular Aging
Current Pharmaceutical Design Lipid Membrane; A Novel Target for Viral and Bacterial Pathogens
Current Drug Targets Progress in Developing D3 Dopamine Receptor Ligands as Potential Therapeutic Agents for Neurological and Neuropsychiatric Disorders
Current Pharmaceutical Design Multitasking of Neuropeptide Y through the Lens of Motifs
Recent Patents on CNS Drug Discovery (Discontinued) Neuroprotection and Behavior Regulation by Adrenomedullin and PAMP as Shown by Conditional Knockout Models
Current Hypertension Reviews Significance of P2X7 Receptor Variants to Human Health and Disease
Recent Patents on DNA & Gene Sequences Tolerance in Intestinal Inflammation and Cancer
Current Drug Targets